Start Date
May 15, 2017
Primary Completion Date
May 16, 2017
Study Completion Date
May 16, 2017
Bifidobacterium
Each B. infantis (strain: BIEVC001) dose will be provided in one 625 mg sachet delivering 156 mg of live bacteria at a dose of 9x10\^9 CFU plus 469 mg of pharmaceutical-grade lactose as the excipient and dispensed to participants by the study personnel.
University of California, Davis Medical Center, Sacramento
Collaborators (1)
Evolve BioSystems, Inc.
INDUSTRY
University of California, Davis
OTHER